Detalhe da pesquisa
1.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Nature
; 580(7804): 517-523, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32322066
2.
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
Br J Cancer
; 129(8): 1327-1338, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620410
3.
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol
; 163(2): 327-338, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237151
4.
Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells.
Bioorg Chem
; 134: 106456, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913879
5.
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.
Can J Neurol Sci
; 50(2): 234-242, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022089
6.
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.
Int J Mol Sci
; 24(21)2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958662
7.
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes.
Int J Mol Sci
; 22(19)2021 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638742
8.
Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
J Neurooncol
; 144(1): 33-41, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197598
9.
Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
J Neurooncol
; 138(3): 487, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29549621
10.
ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
J Neurooncol
; 138(3): 479-486, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520610
11.
A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
Acta Neuropathol
; 133(4): 645-660, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032215
12.
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.
Neuro Oncol
; 26(3): 553-568, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702430
13.
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Stem Cells
; 30(6): 1064-75, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415968
14.
Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs.
J Med Chem
; 66(15): 10639-10657, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449818
15.
Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.
Pharmaceutics
; 15(2)2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839777
16.
Challenges in glioblastoma research: focus on the tumor microenvironment.
Trends Cancer
; 9(1): 9-27, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400694
17.
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.
Clin Transl Med
; 12(7): e939, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35808822
18.
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.
BMC Cancer
; 11: 124, 2011 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21477311
19.
Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.
Cell Death Dis
; 12(8): 763, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344865
20.
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist.
Cell Death Dis
; 12(7): 647, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168123